ERA4TB announced on the 4th Consortium Meeting that CIM – Sant Pau (IIB Sant Pau) has become a new partner with the goal of conducting First Time in Human (FTIH) activities within work package 7 (WP7) with other five Phase I Clinical Trials Units (CTUs).
CIM Sant Pau began its activities in 1983, in partnership with the clinical pharmacology department of the Hospital de la Santa Creu i Sant Pau and the pharmacology and therapeutics department of the Autonomous University of Barcelona. CIM Sant Pau is functionally and organizationally part of the Biomedical Research Platform of Sant Pau Biomedical Research Institute (IIB Sant Pau).
“We want to collaborate in this European project, contributing with our expertise and professionalism carrying out phase 1 trials with excellence. We are a multidisciplinary team, covering all health areas in order to ensure a great study performance.”
Read more about CIM – Sant Pau here
